Bespoke Extracts (BSPK) Preferred Shares (2012 - 2024)
Bespoke Extracts (BSPK) reported Preferred Shares of $24000.0 for Q4 2024, up 2399900.0% sequentially from $1.0 in Q2 2020.
Bespoke Extracts (BSPK) Preferred Shares (2012 - 2024) Analysis & Trends
Bespoke Extracts (BSPK) has 6 years of Preferred Shares data on file, last reported at $24000.0 in Q4 2024.
- For the quarter ending Q4 2024, Preferred Shares changed N/A year-over-year to $24000.0; the trailing twelve-month figure through Dec 2024 stood at $24000.0 (changed N/A YoY), and the FY2024 full-year result was $24000.0, changed N/A from the prior year.
- Preferred Shares grew to $24000.0 in Q4 2024, from $1.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $24000.0 in Q4 2024 to a low of $1.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 24,000.00 |
| May 31, 2020 | 1.00 |
| Feb 29, 2020 | 1.00 |
| Nov 30, 2019 | 1.00 |
| May 31, 2014 | 1.00 |
| Feb 28, 2014 | 1.00 |
| Nov 30, 2013 | 1.00 |
| Aug 31, 2013 | 1.00 |
| May 31, 2013 | 1.00 |
| Feb 28, 2013 | 1.00 |
| Nov 30, 2012 | 1.00 |
| Aug 31, 2012 | 1.00 |